Concepedia

Sreekanth C. Narayanapillai

SC

Statistics

Publications

17

Citations

587

H-Index

15

Active since

2011

Affiliations

University of Minnesota(Current)

University of Florida

University of Minnesota Medical Center

Texas Tech University

University of Florida Health

Sreekanth C. Narayanapillai is an author at University of Minnesota specializing in pharmacology, carcinogenesis, and medicine.

Publications per year

2011–2022

17

Publications

17

Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search

Chunlin Zhuang, Sreekanth C. Narayanapillai, Wannian Zhang et al. · Journal of Medicinal Chemistry · 2014 · 153 citations · Full text

, , +17

Silibinin Is a Potent Sensitizer of UVA Radiation‐induced Oxidative Stress and Apoptosis in Human Keratinocyte HaCaT Cells<sup>†</sup>

Sreekanth C. Narayanapillai, Chapla Agarwal, Cynthia Tilley et al. · Photochemistry and Photobiology · 2011 · 45 citations

, , +17

Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice

Sreekanth C. Narayanapillai, Pablo Leitzman, M. Gerard O’Sullivan et al. · Chemical Research in Toxicology · 2014 · 44 citations · Full text

, , +13

4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions

Manohar Puppala, Xinghua Zhao, Denise Casemore et al. · Bioorganic & Medicinal Chemistry · 2016 · 44 citations · Full text

, , +5

Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice

Sreekanth C. Narayanapillai, Silvia Balbo, Pablo Leitzman et al. · Carcinogenesis · 2014 · 43 citations · Full text

, , +13

1–5 of 17